Centre for Addiction and Mental Health
Toronto, Ontario, M2N5E6, Canada
NCT Number: NCT03043417
This project is measuring the effectiveness of an anti-stigma intervention among primary care providers. Both staff and clients will be asked to complete survey data in order to measure the effectiveness. This is a randomized control trial in that three health centres will receive the intervention and three will not. Results will determine if this intervention reduces stigma among staff toward people with a mental health problem and/or substance use problem.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Toronto, Ontario, M2N5E6, Canada
The Office of Transformative Global Health at the Centre for Addiction and Mental Health (CAMH), with funding provided by the Canadian Institutes of Health Research (CIHR), has developed and will be implementing a three year anti-stigma study. This project is a randomized control study which compares the effectiveness of an anti-stigma intervention in three Toronto community health centres. Six centres were selected and randomized so that three receive the intervention and the other three do not. The goal is to determine if the intervention impacts service providers' attitudes and behaviours towards people with mental health problems and addictions. Additionally, the study measures client's perceptions of stigma in order to see if they believe stigma has been reduced or eliminated. The interventions incorporate the following components: innovative contact-based training, raising awareness, recovery-based arts, and a thorough analysis of each centre's policies and procedures.
Innovative contact-based training utilizes an adult education model and focuses on the results of a preliminary situational assessment conducted at each site. Emphasis is placed on concurrent disorders, cultural issues, and inter-professional collaboration. Four three-hour workshops were held at each intervention CHC throughout the project period and included a needs-based curriculum, contact-based education to reduce prejudice and social intolerance, and culturally competent care for vulnerable populations. Raising awareness includes various forms of media such as posters to increase awareness about stigma.
Recovery-based arts was geared towards a local team of leaders who selected one art form for their CHC and were taught by an art expert. Approximately ten service users with a mental health and/or substance abuse problem were invited to participate along with three staff members. After 10 bi-weekly art workshops, staff and clients will showcase their work at each CHC. Finally, an analysis of policies and procedures have been conducted by research staff. This determines what already exists and using an anti-stigma/pro-recovery approach to identify strengths and areas for improvement. Program and policies were studied to identify unintended positive and negative impacts using a modified version of the Health Equity Assessment Tool. Features of the Quality Rights Tool Kit were also used. Recommendations from this process will be developed and shared with each CHC.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CHC's NOT given the intervention
Time frame: 2 years
The OMS-HC is a 20-item Canadian scale that was developed specifically to measure stigma among healthcare providers toward individuals with mental illness.This scale has good internal consistency (Cronbach's alpha = 0.82), satisfactory test-retest reliability, intra-class correlation (0.66; 95% CI: 0.54-0.75)59 and sensitivity to change.
Time frame: 2 years
MICA is a 16-item scale that was also designed to measure attitudes among healthcare workers toward individuals with mental illness.The MICA scale has good internal consistency (Cronbach's alpha = 0.79), with a test-retest reliability (concordance) of 0.80 (95% CI: 0.68-0.91).
Time frame: 2 years
The Modified Borgadus Social Distance Scale is based on the Borgadus Social Distance Scale.Our study will use a modified six-item version of this scale, focusing specifically on persons with one key mental illness (schizophrenia) and one key addiction (heroin dependence).
Centre for Addiction and Mental Health
Other
Exploring Stigma, Discrimination, and Recovery-based Perspectives Toward Mental Illness and Substance Use Problems
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282173
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Cape Town, Western Cape, South Africa
View Trial DetailsNCT05700474
Behavior, Chemically-Induced Disorders
Charlotte, North Carolina, United States
View Trial DetailsNCT04523337
Chemically-Induced Disorders, Homelessness
Little Rock, Arkansas, United States
View Trial DetailsNCT06172075
Behavior, Behavioral Symptoms
New York, United States
View Trial Details